Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
Titel:
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
Auteur:
Houot, R. Le Gouill, S. Ojeda Uribe, M. Mounier, C. Courby, S. Dartigeas, C. Bouabdallah, K. Alexis Vigier, M. Moles, M.P. Tournilhac, O. Arakelyan, N. Rodon, P. El Yamani, A. Sutton, L. Fornecker, L. Assouline, D. Harousseau, J.L. Maisonneuve, H. Caulet-Maugendre, S. Gressin, R.